difficult breathing
abdominal cramp
relative excess
change in the pattern
spotty menstruation
contraindication
hepatocellular carcinoma in the united state
several non contraceptive health benefit
combine oral contraceptive on the risk of cervical adenocarcinoma
risk of gallbladder disease
woman with a previous history of thrombotic disease
appetite
cardiovascular
venous thromboembolism
pulmonary embolism
oral contraceptive
sign of a blood clot in the lung
acne
iron deficiency anemia
dysmenorrhea
estrogen in oral contraceptive combination
pelvic inflammatory disease in woman
sleep problem
increase blood pressure
speech
world health organization committee
progestin component of these formulation
association between oral contraceptive use
intrahepatic cholestasis
liver problem
woman
available oral contraceptive combination
emergency
retinal thrombosis
edema
weakness
stop
side of the body
ethinyl estradiol
available preparation
chest pain
vomit
develop country
manufacturer of oral contraceptive product
foot
headache or
wheeze
gallbladder disease
arterial thrombosis
association
nausea
shoulder
preexist systemic disease
jaundice
abdominal distention
association with oral contraceptive
investigator
breast lump
moderate progestin
risk of epithelial ovarian cancer
hive
oily skinbreast tendernessdepressiontiredness
systemic lupus erythematosus
light vaginal bleeding
well differentiate hepatocellular carcinoma
myocardial infarction
dizziness
nausea vomit bloat
cardiovascular system
case of fatal pulmonary occlusive disease
severity of migraine headache
specific group of woman
bleedingincreased spottinghypomenorrhea
higher risk for endometrial carcinoma than other woman
ovarian cancer
oral contraceptive combination
significant blood pressure
public health importance in the united state
sudden cough
possible relationship between the use of oral contraceptive
loss of scalp hair
acne vulgaris
problem with vision
tired feeling
ectopic pregnancy
depression
woman experience oligomenorrhea
older formulation
appetiteweight
hepatitis b virus infection
exogenous estrogen
protection against ovarian cancer
vascular thrombosis
benefit
underlie
vaginal itching
focal nodular hyperplasia
detailed information
mood change
clay color stool
cause
large number of confounding factor
vaginitis
short term use of oral contraceptive
leg
neoplasm of the uterine cervix
underlie cardiovascular disease
strong association between oral contraceptive use
breast tenderness
pressure
protection
careful review of a woman
incidence of hospitalization for pelvic inflammatory disease
cough
geographic tongue
change
severe lipidemia
progestin in a
sudden numbness
committee of the world health organization
liver cell adenoma
alteration in lipid profile
problem with contact lens
hair growth
termination
long term risk for mortality
antiestrogen
use of oral contraceptive
smoke
jaw
nauseaheadachemelasmahypertensionbreast tendernessedemaestrogen deficiency
tongue
heart attack symptom
most woman
breakthrough bleeding
increase ldl cholesterol level
cholesterol level
hdl
overall association between oral contraceptive use
non hormonal cause of such bleeding
case of venous thrombosis
dark urine
malignant neoplasm
cardiovascular risk factor before a decision
late breakthrough bleedingamenorrheahypermenorrheaestrogen
gaincholestatic jaundiceprogestin deficiency
case of oral contraceptive induce esophageal ulceration
risk
woman on oral contraceptive combination product
sweating
oral contraceptive use
conception delay
eye
investigation into the epidemiology of this neoplasm
addition
observe association
use birth control pill
oral contraceptive user
ethynodiol
development of new case of cancer
use of oral contraceptive combination
hepatocellular carcinoma
young woman
other western nation
ovarian cyst
breast change
precipitation of panic disorder
nulliparous woman
risk of ovarian cancer
warmth
insufficient datum
headache
risk of breast cancer
loss of appetite
pelvic inflammatory disease
increase risk
give product
early mid cycle breakthrough
mcg
complex alteration in plasma lipid profile
deficiency of the estrogen
rapid breathing
ankle
symptom of depression
other risk factor
such woman
possible relationship between oral contraceptive use
sign of a stroke
change in weight
treated woman
yellow of the skin
breast cancer
glucose tolerance
stroke
same committee
bias
exogenous progestin
hepatic granuloma
balance
fatiguehair
sudden severe headache
estrogen
variation in the hormonal content of oral contraceptive
general
exist vascular disease
weak association between long term use of oral contraceptive
development of breast cancer
exist
change in contact lens tolerance
throat
early investigation of woman
other investigator
long term use
risk of endometrial cancer
redness
freckle
significant hypertension
severity
migraine
adenocarcinoma of the cervix
endometrial carcinoma
chorea
other
lip
accelerate growth
finding
thromboembolism
nervous system
recent large investigation of woman
young diabetic woman
firm conclusion
deficiency of these component
fever
pain
amenorrhea
vulvovaginal candidiasis
family history of breast cancer
menstrual period
swell
epidermoid carcinoma
spot
first several cycle of oral contraceptive use
hand
number of investigation
long term use of oral contraceptive
relative amount
blood
darken of facial skin
previous thrombotic disease
discharge
preexist
thrombotic stroke
sign of a blood clot
relative risk of hepatocellular carcinoma
carbohydrate metabolism
lower risk
hepatic hemangioma
exist cancer
face
menstrual irregularity
severe stomach pain
potency of the specific estrogen
progestin
cause favorable change in lipid profile
increase risk of dysplasia
actual number of case of liver cancer in the united state